Given the essential role of T cells in malaria immunity, especially at the pre-erythrocytic stage, designing vaccines that effectively stimulate both CD8+ and CD4+ responses is a critical step toward enhancing protection and blocking transmission. This evidence concerns the gene CD4 and malaria.